Catalyst Wire Dossier Catalyst Wire Dossier
EMA approval · 2023-11-13

EMA Authorised: Sildenafil Actavis (sildenafil) — Actavis Group PTC ehf

View source ↗

Summary

Regulatory authorization granted for Sildenafil Actavis (sildenafil) for erectile dysfunction by EMA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sildenafil Actavis (sildenafil)

Snippet

Status: Authorised. Therapeutic area: Erectile Dysfunction. MAH: Actavis Group PTC ehf. Decision date: 10/11/2023